|
Timothy Falla, Ph.D. is our Vice President and Chief Scientific Officer. Dr. Falla joined the Company as Chief Scientific Officer in June 2001 and was appointed as a Vice President in December 2001. He is responsible for developing the Company's science and technology and for its application to clinical and non-clinical product candidates. Prior to joining the Company, Dr. Falla was employed by IntraBiotics Pharmaceuticals, Inc., a biopharmaceutical company developing novel antibacterial and antifungal drugs for the prevention or treatment of serious infectious diseases. As Principal Scientist he led a multi-disciplinary scientific research team focused on antibacterial drug discovery and development. Prior to his tenure with IntraBiotics Dr. Falla held research associate positions at the University of British Columbia and The Antimicrobial Research Centre at the University of Leeds. Dr. Falla received his Bachelor of Science degree in Applied Biology from the University of Wales in 1989, and obtained his Ph.D. in the Molecular Biology of Infectious Disease from Oxford University and the University of Wales in 1993. | 